IHE

iShares U.S. Pharmaceuticals ETF
*Unless otherwise stated, data provided by FactSet.

IHE Fund Description

IHE tracks a broad-based, cap-weighted index of US pharmaceutical companies.

IHE Factset Analytics Insight

IHE tracks a broad index of US pharmaceutical companies. The fund provides exposure to the manufacturers of prescription or over-the-counter drugs, such as aspirin, cold remedies and birth control pills. The index also includes vaccine producers. IHE may also include companies of all sizes, ranging from large- to small-cap. The index weights its constituents by market cap, with a cap of up to 22.5% per individual company and is rebalanced quarterly. IHE uses a sampling strategy that involves investing in a representative sample of securities that collectively has an investment profile similar to that of an applicable underlying index. Index components are selected on an annual basis.

IHE MSCI ESG Analytics Insight

iShares U.S. Pharmaceuticals ETF has an MSCI ESG Fund Rating of BB based on a score of 4.18 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. iShares U.S. Pharmaceuticals ETF ranks in the 15th percentile within its peer group and in the 25th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

IHE MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

PERFORMANCE [as of 06/18/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
IHE 1.62% 4.07% 5.10% 25.17% 7.87% 7.26% 11.84%
IHE (NAV) 0.37% 3.99% 3.48% 23.05% 7.63% 6.94% 11.67%
DJ US Select / Pharmaceutical 0.40% 4.08% 3.62% 23.51% 7.97% 7.24% 12.03%
Thomson Reuters US Pharmaceuticals 0.65% 7.40% 8.19% 21.65% 14.02% 10.71% 13.77%
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

IHE Summary Data

Blackrock
iShares
05/01/06
Open-Ended Fund
0.42%
$374.05M
$1.12M
0.07%

IHE Portfolio Data

$173.11B
90.73
3.66
1.39%
06/10/21
45

IHE Index Data

DJ US Select / Pharmaceutical
Market Cap
Market Cap
Thomson Reuters US Pharmaceuticals

IHE Portfolio Management

0.42%
-0.50%
-0.38%
-0.63%

IHE Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

IHE Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
Low
Daily

IHE Factset Analytics Block Liquidity

As of 06/21/21
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of IHE. IHE is rated a 5 out of 5.

IHE Tradability

6,099
$1.12M
4,622
$835.38K
0.07%
$0.12
0.01%
0.20% / -0.36%
None
95.00%
50,000
0.09
0.00%
0.25%
37
$184.55
5

IHE Sector/Industry Breakdown


IHE
Segment Benchmark
75.77%
87.95%
9.53%
5.46%
6.66%
0.02%
2.20%
--
0.90%
5.38%
0.50%
0.07%
0.15%
0.15%

IHE Countries


IHE
Segment Benchmark
100.00%
100.00%

IHE Regions


IHE
Segment Benchmark
100.00%
100.00%

IHE Economic Development


IHE
Segment Benchmark
100.00%
100.00%

IHE Performance Statistics

0.77
0.90
0.85
0.92
0.45%
Thomson Reuters US Pharmaceuticals

IHE MSCI ESG Ratings

4.18 / 10
25.42
15.07
--
11.28%
28.63

IHE Benchmark Comparison Holdings

45
69
25
59.83%

IHE Benchmark Comparison Summary


IHE
Segment Benchmark
45
69
$173.11B
$220.95B
90.73
41.99
3.66
5.87
1.75%
2.53%
High
High

IHE Benchmark Comparison Market Cap Size


IHE
Segment Benchmark
79.75%
96.00%
11.07%
2.42%
8.35%
1.29%
0.83%
0.29%